Table 2.
Case report form | Feature-based CDEs |
---|---|
CT | Hypodensity, hyperdensity, enhancement |
MRI |
Decreased volume, increased volume, diffusion restriction, T2-weighted hyperintensity, susceptibility-weighted or T2*-weighted hypointensity, enhancement, cystic changes |
CT Perfusion | CBF, MTT, Time to peak, or TMax abnormalities |
MR Perfusion | |
MR Spectroscopy | Metabolite abnormalities: N-acetyl- aspartate, Choline, Creatine, Myo-inositol, Lactate, Glutamine/glutamate |
PET | Localization of tracer uptake |
CBF cerebral blood flow, CDE common data element, CT computed tomography, MTT mean transit time, MRI magnetic resonance imaging, TMax time to maximum